- Home>
- Specialties>
- HIV/AIDS Clinical Care>
- AIDS Watch
Lopinavir/r Preferred for Children Exposed to Nevirapine at Birth
Children who receive single-dose nevirapine at birth may have better rates of virologic suppression with subsequent antiretroviral regimens that contain lopinavir/ritonavir than with those that contain nevirapine, according to a recent press release from the National Institute of Allergy and Infectious Diseases. This finding emerged during an interim analysis of the P1060 trial in Asia and Africa and is consistent with current WHO recommendations regarding antiretroviral regimens in children previously exposed to nevirapine.
Published in Journal Watch HIV/AIDS Clinical Care May 18, 2009
Citation(s):
Ritonavir-boosted lopinavir proves superior to nevirapine in HIV-infected infants who received single-dose nevirapine at birth [press release]. Bethesda, MD: National Institute of Allergy and Infectious Diseases; May 6 , 2009. (http://www3.niaid.nih.gov/news/newsreleases/2009/P1060.htm)
Your Remark:
To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.
